Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent
Identifieur interne : 002295 ( Main/Exploration ); précédent : 002294; suivant : 002296Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent
Auteurs : Jill C. Mwenifumbo [Canada] ; Nael Al Koudsi [Canada] ; Man Ki Ho [Canada] ; Qian Zhou [Canada] ; Ewa B. Hoffmann [Canada] ; Edward M. Sellers [Canada] ; Rachel F. Tyndale [Canada]Source :
- Human Mutation [ 1059-7794 ] ; 2008-05.
English descriptors
Abstract
Cytochrome P450 2A6 (CYP2A6) is a human enzyme best known for metabolizing tobacco‐related compounds, such as nicotine, cotinine (COT), and nitrosamine procarcinogens. CYP2A6 genetic variants have been associated with smoking status, cigarette consumption, and tobacco‐related cancers. Our objective was to functionally characterize four nonsynonymous CYP2A6 sequence variants with respect to their haplotype, allele frequency, and association with in vivo CYP2A6 activity. In vivo, nicotine was administered orally to 281 volunteers of Black African descent. Blood samples were collected for kinetic phenotyping and CYP2A6 genotyping. In vitro, nicotine C‐oxidation catalytic efficiencies of heterologously expressed variant enzymes were assessed. The four uncharacterized sequence variants were found in seven novel alleles CYP2A6*24A&B, *25, *26, *27, and *28A&B; most were associated with impaired in vivo CYP2A6 activity. Nicotine metabolism groupings, based on the in vivo data of variant alleles, were created. Mean trans‐3′‐hydroxycotinine/cotinine (3HC/COT) differed (P<0.001) between normal (100%), intermediate (64%), and slow (40%) groups. Systemic exposure to nicotine following oral administration also differed (P<0.001) between normal (100%), intermediate (139%), and slow (162%) metabolism groups. In addition, alleles of individuals with unusual phenotype–genotype relationships were sequenced, resulting in the discovery of five novel uncharacterized alleles and at least one novel duplication allele. A total of 7% of this population of Black African descent had at least one of the eight novel characterized alleles and 29% had at least one previously established allele. These findings are important for increasing the accuracy of association studies between CYP2A6 genotype and behavioral, disease, or pharmacological phenotypes. Hum Mutat 29(5), 679–688, 2008. © 2008 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/humu.20698
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001131
- to stream Istex, to step Curation: 001131
- to stream Istex, to step Checkpoint: 000898
- to stream Main, to step Merge: 002488
- to stream Main, to step Curation: 002295
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent</title><author><name sortKey="Mwenifumbo, Jill C" sort="Mwenifumbo, Jill C" uniqKey="Mwenifumbo J" first="Jill C." last="Mwenifumbo">Jill C. Mwenifumbo</name></author><author><name sortKey="Al Koudsi, Nael" sort="Al Koudsi, Nael" uniqKey="Al Koudsi N" first="Nael" last="Al Koudsi">Nael Al Koudsi</name></author><author><name sortKey="Ho, Man Ki" sort="Ho, Man Ki" uniqKey="Ho M" first="Man Ki" last="Ho">Man Ki Ho</name></author><author><name sortKey="Zhou, Qian" sort="Zhou, Qian" uniqKey="Zhou Q" first="Qian" last="Zhou">Qian Zhou</name></author><author><name sortKey="Hoffmann, Ewa B" sort="Hoffmann, Ewa B" uniqKey="Hoffmann E" first="Ewa B." last="Hoffmann">Ewa B. Hoffmann</name></author><author><name sortKey="Sellers, Edward M" sort="Sellers, Edward M" uniqKey="Sellers E" first="Edward M." last="Sellers">Edward M. Sellers</name></author><author><name sortKey="Tyndale, Rachel F" sort="Tyndale, Rachel F" uniqKey="Tyndale R" first="Rachel F." last="Tyndale">Rachel F. Tyndale</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B09E5DFA9E056692085B9F08AAC274286C24DE48</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/humu.20698</idno><idno type="url">https://api-v5.istex.fr/document/B09E5DFA9E056692085B9F08AAC274286C24DE48/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001131</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001131</idno><idno type="wicri:Area/Istex/Curation">001131</idno><idno type="wicri:Area/Istex/Checkpoint">000898</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000898</idno><idno type="wicri:doubleKey">1059-7794:2008:Mwenifumbo J:novel:and:established</idno><idno type="wicri:Area/Main/Merge">002488</idno><idno type="wicri:Area/Main/Curation">002295</idno><idno type="wicri:Area/Main/Exploration">002295</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent</title><author><name sortKey="Mwenifumbo, Jill C" sort="Mwenifumbo, Jill C" uniqKey="Mwenifumbo J" first="Jill C." last="Mwenifumbo">Jill C. Mwenifumbo</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Al Koudsi, Nael" sort="Al Koudsi, Nael" uniqKey="Al Koudsi N" first="Nael" last="Al Koudsi">Nael Al Koudsi</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Ho, Man Ki" sort="Ho, Man Ki" uniqKey="Ho M" first="Man Ki" last="Ho">Man Ki Ho</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Zhou, Qian" sort="Zhou, Qian" uniqKey="Zhou Q" first="Qian" last="Zhou">Qian Zhou</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Hoffmann, Ewa B" sort="Hoffmann, Ewa B" uniqKey="Hoffmann E" first="Ewa B." last="Hoffmann">Ewa B. Hoffmann</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Sellers, Edward M" sort="Sellers, Edward M" uniqKey="Sellers E" first="Edward M." last="Sellers">Edward M. Sellers</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Tyndale, Rachel F" sort="Tyndale, Rachel F" uniqKey="Tyndale R" first="Rachel F." last="Tyndale">Rachel F. Tyndale</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pharmacology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Human Mutation</title><title level="j" type="abbrev">Hum. Mutat.</title><idno type="ISSN">1059-7794</idno><idno type="eISSN">1098-1004</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-05">2008-05</date><biblScope unit="volume">29</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="679">679</biblScope><biblScope unit="page" to="688">688</biblScope></imprint><idno type="ISSN">1059-7794</idno></series><idno type="istex">B09E5DFA9E056692085B9F08AAC274286C24DE48</idno><idno type="DOI">10.1002/humu.20698</idno><idno type="ArticleID">HUMU20698</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1059-7794</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>3HC/COT</term><term>Black African descent</term><term>CYP2A6</term><term>genetic variation</term><term>nicotine metabolism</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cytochrome P450 2A6 (CYP2A6) is a human enzyme best known for metabolizing tobacco‐related compounds, such as nicotine, cotinine (COT), and nitrosamine procarcinogens. CYP2A6 genetic variants have been associated with smoking status, cigarette consumption, and tobacco‐related cancers. Our objective was to functionally characterize four nonsynonymous CYP2A6 sequence variants with respect to their haplotype, allele frequency, and association with in vivo CYP2A6 activity. In vivo, nicotine was administered orally to 281 volunteers of Black African descent. Blood samples were collected for kinetic phenotyping and CYP2A6 genotyping. In vitro, nicotine C‐oxidation catalytic efficiencies of heterologously expressed variant enzymes were assessed. The four uncharacterized sequence variants were found in seven novel alleles CYP2A6*24A&B, *25, *26, *27, and *28A&B; most were associated with impaired in vivo CYP2A6 activity. Nicotine metabolism groupings, based on the in vivo data of variant alleles, were created. Mean trans‐3′‐hydroxycotinine/cotinine (3HC/COT) differed (P<0.001) between normal (100%), intermediate (64%), and slow (40%) groups. Systemic exposure to nicotine following oral administration also differed (P<0.001) between normal (100%), intermediate (139%), and slow (162%) metabolism groups. In addition, alleles of individuals with unusual phenotype–genotype relationships were sequenced, resulting in the discovery of five novel uncharacterized alleles and at least one novel duplication allele. A total of 7% of this population of Black African descent had at least one of the eight novel characterized alleles and 29% had at least one previously established allele. These findings are important for increasing the accuracy of association studies between CYP2A6 genotype and behavioral, disease, or pharmacological phenotypes. Hum Mutat 29(5), 679–688, 2008. © 2008 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="Canada"><region name="Ontario"><name sortKey="Mwenifumbo, Jill C" sort="Mwenifumbo, Jill C" uniqKey="Mwenifumbo J" first="Jill C." last="Mwenifumbo">Jill C. Mwenifumbo</name></region><name sortKey="Al Koudsi, Nael" sort="Al Koudsi, Nael" uniqKey="Al Koudsi N" first="Nael" last="Al Koudsi">Nael Al Koudsi</name><name sortKey="Ho, Man Ki" sort="Ho, Man Ki" uniqKey="Ho M" first="Man Ki" last="Ho">Man Ki Ho</name><name sortKey="Hoffmann, Ewa B" sort="Hoffmann, Ewa B" uniqKey="Hoffmann E" first="Ewa B." last="Hoffmann">Ewa B. Hoffmann</name><name sortKey="Hoffmann, Ewa B" sort="Hoffmann, Ewa B" uniqKey="Hoffmann E" first="Ewa B." last="Hoffmann">Ewa B. Hoffmann</name><name sortKey="Sellers, Edward M" sort="Sellers, Edward M" uniqKey="Sellers E" first="Edward M." last="Sellers">Edward M. Sellers</name><name sortKey="Tyndale, Rachel F" sort="Tyndale, Rachel F" uniqKey="Tyndale R" first="Rachel F." last="Tyndale">Rachel F. Tyndale</name><name sortKey="Tyndale, Rachel F" sort="Tyndale, Rachel F" uniqKey="Tyndale R" first="Rachel F." last="Tyndale">Rachel F. Tyndale</name><name sortKey="Zhou, Qian" sort="Zhou, Qian" uniqKey="Zhou Q" first="Qian" last="Zhou">Qian Zhou</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002295 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002295 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B09E5DFA9E056692085B9F08AAC274286C24DE48
|texte= Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent
}}
| This area was generated with Dilib version V0.6.29. |  |